CLYM Sale Disclosure
Thomas Stephen Basil · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$1.37M
Thomas Stephen Basil Director
CLYM
Climb Bio
CLYM
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
CLYM daily price context
Close on/before transaction
$13.91
Sep 15, 2026
Close before public filing
$14.11
Sep 16, 2026
Return since public filing
+0.99%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 100,000 shares @ $13.67
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-394357
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$1.37M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Climb Bio, Inc. CLYM Current | Sale | Sep 15, 2026 | $1.37M |